arrow
M

Michel Obéid

university oflausanne
H指数:30
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune checkpoint inhibitor-associated myocarditis: a novel risk score

免疫检查点抑制剂相关心肌炎:一种新型风险评分

2025-06-180
PRE
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy

托珠单抗和免疫特征用于免疫检查点治疗中细胞因子释放综合征的靶向管理

2024-12-011
OAAI
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023)
2024-01-032
OA
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (oct, 10.1038/s41591-023-02591-2, 2023)
2023-11-270
OA
A differential process mining analysis of COVID-19 management for cancer patients

癌症患者新型冠状病毒肺炎管理的差异化过程挖掘分析

2022-12-074
OAAI
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events

与自身免疫性肝病的系统比较可确定免疫检查点抑制剂相关不良事件的特定组织学特征

2022-10-2520
OAAI
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
2021-11-1769
OAAI